This is in line with previous reports showing that, in different thyroid cancer models, co-expression of p53 and TAp73α may alternatively result in TAp73α down-regulation [62] or stronger p53 tumor suppressor activity [73]. This evidence concerns the gene TP53 and thyroid gland carcinoma.